Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hepatitis

  Free Subscription


28.05.2018

2 Dig Dis Sci
2 Hepatology
3 J Hepatol
1 J Interferon Cytokine Res
2 PLoS One
2 PLoS Pathog
1 Vaccine


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Dig Dis Sci

  1. PRIVITERA G, Spadaro L, Marchisello S, Fede G, et al
    Abnormalities of Lipoprotein Levels in Liver Cirrhosis: Clinical Relevance.
    Dig Dis Sci. 2017 Nov 25. pii: 10.1007/s10620-017-4862.
    PubMed     Text format     Abstract available

  2. DONG J, Ying J, Qiu X, Lu Y, et al
    Advanced Strategies for Eliminating the cccDNA of HBV.
    Dig Dis Sci. 2018;63:7-15.
    PubMed     Text format     Abstract available


    Hepatology

  3. LIU N, Liu Q, Yang X, Zhang F, et al
    Hepatitis B virus-upregulated lnc-HUR1 promotes cell proliferation and tumorigenesis by blocking p53 activity.
    Hepatology. 2018 May 23. doi: 10.1002/hep.30098.
    PubMed     Text format     Abstract available

  4. COURI T, Gupta T, Weyer G, Aronsohn A, et al
    Pay It Forward: Building Capacity to Treat Hepatitis C by Training Our Own Residents.
    Hepatology. 2018 May 23. doi: 10.1002/hep.30101.
    PubMed     Text format    


    J Hepatol

  5. VAN EIJK JJJ, Cintas P, Jacobs BC, Kamar N, et al
    Reply to: "Association of hepatitis E virus infection and myasthenia gravis: A pilot study".
    J Hepatol. 2018;68:1321-1322.
    PubMed     Text format    

  6. DE MARTIN E, Michot JM, Champiat S, Lambotte O, et al
    Reply to: "Immune-related hepatitis with immunotherapy: Are corticosteroids always needed?"
    J Hepatol. 2018 May 15. pii: S0168-8278(18)32030.
    PubMed     Text format    

  7. PEERAPHATDIT TB, Simonetto DA, Shah VH
    Exploring new treatment paradigms for alcoholic hepatitis by extrapolating from NASH and cholestasis.
    J Hepatol. 2018 May 21. pii: S0168-8278(18)32058.
    PubMed     Text format    


    J Interferon Cytokine Res

  8. CAO WH, Li MH, Pan CQ, Lu Y, et al
    Quantitation of Plasmacytoid Dendritic Cells in Chronic Hepatitis B Patients with HBeAg Positivity During PEG-IFN and Entecavir Therapy.
    J Interferon Cytokine Res. 2018;38:197-205.
    PubMed     Text format     Abstract available


    PLoS One

  9. FENG Y, Feng YM, Wang S, Xu F, et al
    High seroprevalence of hepatitis E virus in the ethnic minority populations in Yunnan, China.
    PLoS One. 2018;13:e0197577.
    PubMed     Text format     Abstract available

  10. TSUKAMOTO Y, Ikeda S, Uwai K, Taguchi R, et al
    Rosmarinic acid is a novel inhibitor for Hepatitis B virus replication targeting viral epsilon RNA-polymerase interaction.
    PLoS One. 2018;13:e0197664.
    PubMed     Text format     Abstract available


    PLoS Pathog

  11. LIU K, Luckenbaugh L, Ning X, Xi J, et al
    Multiple roles of core protein linker in hepatitis B virus replication.
    PLoS Pathog. 2018;14:e1007085.
    PubMed     Text format     Abstract available

  12. LIANG Y, Cao X, Ding Q, Zhao Y, et al
    Hepatitis C virus NS4B induces the degradation of TRIF to inhibit TLR3-mediated interferon signaling pathway.
    PLoS Pathog. 2018;14:e1007075.
    PubMed     Text format     Abstract available


    Vaccine

  13. CHUAI X, Xie B, Chen H, Tan X, et al
    The immune response of rhesus macaques to novel vaccines comprising hepatitis B virus S, PreS1, and Core antigens.
    Vaccine. 2018 May 16. pii: S0264-410X(18)30681.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: